Effectively encapsulating the payload to shield it from harsh biological environments (like enzymatic degradation or systemic clearance).
Targeted Drug Delivery for Vaccine
The evolution of therapeutics, including mRNA and cancer vaccines, makes Targeted Delivery decisive for improving immunogenicity, reducing dosage, and ensuring safety. Creative Biolabs provides interdisciplinary professional services to design and optimize customized delivery systems for your next-generation vaccine, ensuring efficient and precise immune activation.
What is Targeted Delivery?
Targeted delivery in vaccinology is the science of precision engineering that transforms a therapeutic cargo—whether a nucleic acid (such as mRNA) or a protein antigen—into an intelligent system. It involves two core principles:
Protection
Direction
Actively guiding the protected cargo to the ideal immune cells, specifically Antigen-Presenting Cells (APCs), like Dendritic Cells (DCs).
This precision approach maximizes the desired immune response while simultaneously minimizing non-specific toxicity and systemic reactogenicity.
Applications for Enhanced Vaccine Efficacy
Advanced delivery systems are crucial across the modern vaccine landscape, enhancing efficacy regardless of the payload:
Novel Nucleic Acid Vaccines (mRNA/DNA Vaccines)
Provide highly stable and efficient delivery vectors for fragile mRNA/DNA molecules, accelerating the development of vaccines for infectious diseases and emerging pandemic threats.
Therapeutic Cancer Vaccines
Precisely deliver tumor-associated antigens (TAAs) or novel neoantigens, activating a potent CD8+ cytotoxic T lymphocyte (CTL) response for effective tumor clearance and recurrence prevention.
Combined Vaccine & Adjuvant Delivery
Co-encapsulate antigens with novel adjuvants (like TLR agonists) to ensure simultaneous release within the correct cellular compartments, significantly enhancing immunogenicity and achieving synergistic immune activation.
Traditional Subunit & Peptide Vaccines
Serve as highly biocompatible vectors, protecting delicate peptide or protein structures and providing sustained-release functionality, thereby prolonging the duration of immune stimulation to maximize memory response.
Fig.1 Various delivery systems for oral vaccines.1
Addressing the Delivery Challenges of Traditional Methods
The limitations of conventional injection methods underscore the urgent need for advanced carrier technologies:
In Vivo Survival Rate of Nucleic Acids/Antigens Targeting of Antigen-Presenting Cells (APCs) Powerful Cellular Immune Activation
After injection, how can fragile mRNA or protein antigens be protected from rapid degradation by ubiquitous systemic enzymes?
What We Can Offer
We offer professional, customized vaccine delivery services to help your innovative vaccine projects achieve rapid clinical translation and regulatory success:
High-Performance LNP Vaccine Delivery Platform
We provide core technology in lipid nanoparticles (LNPs) and optimize ionizable lipid formulations to achieve superior mRNA/siRNA encapsulation, rapid endosomal escape, and focused lymph node (LN) targeting.
DC Cell Precision Targeting Technology
Utilizing carrier surface ligand modifications (such as mannose or specific peptides) to enhance the specific recognition and uptake by dendritic cells, maximizing APC interaction.
Adjuvant Synergy and Immunomodulation
Developing multifunctional carriers to achieve co-localization and co-delivery of antigens and adjuvants (such as TLR agonists), thereby maximizing specific, tailor-made immune responses (e.g., strong Th1 vs. Th2 bias).
Formulation Scale-up and Quality Control
Providing compliant formulation development and process scale-up services to ensure uniformity, high encapsulation efficiency, and long-term stability of vaccine delivery carriers, accelerating the Investigational New Drug (IND) application process.
Why Choose Creative Biolabs?
Integrated Expertise
Decades of experience in both immunology and nanomedicine.
Scalability Guarantee
Processes optimized for industrial-scale, high-quality production standards.
Targeting Focus
Proprietary technologies specifically designed for APC and lymph node tropism.
Regulatory Intelligence
Dedicated support to navigate the novel nanocarrier regulatory pathway.
Workflow
Achieve your vaccine breakthrough with targeted delivery technology! Your innovative vaccine requires state-of-the-art delivery technology. Please contact our team of vaccine delivery experts to begin engineering your customized solution.
Reference
- Zafar, Amna, et al. "Recent developments in oral delivery of vaccines using nanocarriers." Vaccines 11.2 (2023): 490. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/vaccines11020490.
Our services are For Research Use Only. We do not provide services to individuals.
Online Inquiry
